(Q34240463)

31 July 2017

title

Role of mendelian genes in "sporadic" Parkinson's disease (English)

1 reference

31 July 2017

1 reference

2

0 references

Suzanne Lesage

series ordinal

1

object named as

Suzanne Lesage

1 reference

31 July 2017

publication date

1 January 2012

1 reference

Parkinsonism and Related Disorders

31 July 2017

published in

1 reference

31 July 2017

volume

18 Suppl 1

1 reference

31 July 2017

page(s)

S66-70

1 reference

Parkinson's disease: from monogenic forms to genetic susceptibility factors

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

Translation initiator EIF4G1 mutations in familial Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

VPS35 mutations in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

alpha-Synuclein locus triplication causes Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

How much phenotypic variation can be attributed to parkin genotype?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

Deciphering the role of heterozygous mutations in genes associated with parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

The role of common genetic risk variants in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

A two-stage meta-analysis identifies several new loci for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970022-0

7 January 2021

10.1016/S1353-8020(11)70022-0

Identifiers

DOI

1 reference

31 July 2017

1 reference